Showing Events in 1
Track from 08:00am to
09:45am
Day 2 Morning General Session
Showing Events in 1
Track from 09:45am to
10:20am
Morning Networking Break and Breakfast
Showing Events in 1
Track from 10:20am to
12:25pm
Day 2 Morning General Session Continued
Showing Events in 1
Track from 12:25pm to
01:40pm
Lunch, Networking and Optional Roundtables
Showing Events in 4
Tracks from 01:45pm to
02:45pm
Interactive Session #1 (Liberty A)
Interactive Session #2 (Liberty B)
Interactive Session #3 (Liberty C)
Interactive Session #4 (Liberty D)
Showing Events in 1
Track from 02:45pm to
03:15pm
Afternoon Break & Networking
Showing Events in 3
Tracks from 03:15pm to
05:20pm
Track 1: Patient Experience Data & Returning Data To Patients (Liberty A)
Track Chair:
Jean Stimola-Sposaro, MSJ,
Director, Global Clinical Trial Industry Collaborations, Global Drug Development Operations, BMS
Track 2: DCTs, Digital & Mobile Technologies (Liberty B)
Track Chair:
Christie Fry,
Director, Strategic Technology Innovation, AbbVie
Track 3: DE&I and Community Engagement (Liberty C)
Track Chair:
Tara Gipp,
Director Global Trial Optimization, Patient Engagement, Regeneron Pharmaceuticals Inc
Showing Events in 1
Track from 05:20pm to
06:15pm
End of Day 2
Showing Events in 1
Track from
08:00am to 09:45am
Day 2 Morning General Session
Showing Events in 1
Track from
09:45am to 10:20am
Morning Networking Break and Breakfast
Showing Events in 1
Track from
10:20am to 12:25pm
Day 2 Morning General Session Continued
Showing Events in 1
Track from
12:25pm to 01:40pm
Lunch, Networking and Optional Roundtables
Showing Events in 4
Tracks from
01:45pm to 02:45pm
Interactive Session #1 (Liberty A)
Interactive Session #2 (Liberty B)
Interactive Session #3 (Liberty C)
Interactive Session #4 (Liberty D)
Showing Events in 1
Track from
02:45pm to 03:15pm
Afternoon Break & Networking
Showing Events in 3
Tracks from
03:15pm to 05:20pm
Track 1: Patient Experience Data & Returning Data To Patients (Liberty A)
Track Chair:
Jean Stimola-Sposaro, MSJ,
Director, Global Clinical Trial Industry Collaborations, Global Drug Development Operations, BMS
Track 2: DCTs, Digital & Mobile Technologies (Liberty B)
Track Chair:
Christie Fry,
Director, Strategic Technology Innovation, AbbVie
Track 3: DE&I and Community Engagement (Liberty C)
Track Chair:
Tara Gipp,
Director Global Trial Optimization, Patient Engagement, Regeneron Pharmaceuticals Inc
Showing Events in 1
Track from
05:20pm to 06:15pm